Next Event in the Partnering series
Accelerate licensing and collaboration deals across TAC and Molecular Glue discovery platforms and pipelines to validate capabilities, improve tissue specificity of protein homeostasis, and leverage known, undruggable targets across diseases.
Thank you to our speakers, sponsors, and delegates who joined us in
2024 for the summit! If you are interested in the 2025 event, please get in touch at
info@hansonwade.com
A Snapshot of Attending Companies in 2024:
Targeted Protein Degradation & Induced Proximity Summit
Propelling PROTACs, Glues, & Novel TACs Drugs Towards the First Approval
With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more important to re-join forces at the TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based conference.
Spanning foundational research and discovery, through to IND-filing and clinical trials, this is the world’s definitive meeting to discuss opportunities and challenges the TPD & Induced Proximity field must address to expand the target space and facilitate the discovery and development of therapeutically relevant degraders, blockers, stabilizers and inducers of protein-protein interactions. Whether you’re entering the TPD & Induced Proximity space for the first time or a well-seasoned TPD veteran, this forum will equip you with the knowhow and connections to make rapid advances in your work.
In 2024, the Summit assembled over 450 TPD & Induced Proximity enthusiasts from across every corner of the landscape, we left no stone unturned in our duty to continue to deliver the full breadth and depth of protein degradation and modulation research with SureTACs, EpiTACs, RIPTACs, Molecular Gates, and so much more.
The TPD & Induced Proximity Summit is the field’s singular, one-stop-shop to gain unparalleled overview of cutting-edge R&D, whilst diving deep into end-to-end development strategy to propel degraders towards the first clinical approval. Returning in October 2025, you do not want to miss out!
FULL EVENT GUIDE
Relive the Highlights:
2024 Expert Speakers Included:
Stuart Schreiber
Professor - Morris Loeb. Chemistry & Chemical Biology, Emeritus Howard Hughes Medical Institute Investigator
Arena Bioworks
Companies that Presented for the First Time in 2024:
“Four days of high value content and engaging speakers and moderators - a must for those invested in the field of targeted degradation”
Associate Director
“In such a rapidly evolving field, it is crucial to have a touchpoint to check in on progress across companies. This is an excellent forum to meet the key players in the field and absorb new advances”
Senior Director of Chemistry
“Fantastic speakers, great audience, well organized, the most important conference in the TPD field. Impossible to skip if you want to stay informed of recent developments in the field”
Senior Vice President
Proud to Partner With in 2024:
Expertise Partner:
Program Partners:
Other Events in the Small Molecules & TPD World Series
